Detalhe da pesquisa
1.
Gastric cancer peritoneal metastasis related signature predicts prognosis and sensitivity to immunotherapy in gastric cancer.
J Cell Mol Med
; 27(22): 3578-3590, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37605453
2.
MicroRNA-329 inhibits cell proliferation and tumor growth while facilitates apoptosis via negative regulation of KDM1A in gastric cancer.
J Cell Biochem
; 119(4): 3338-3351, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29130516
3.
Development and Validation of a Prognostic Model for Postoperative Anastomotic Recurrence in Siewert II or III Adenocarcinomas Without Neoadjuvant Therapy in an East Asian Population.
J Gastrointest Cancer
; 2024 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38175384
4.
The safety and efficacy of neoadjuvant immunochemotherapy following laparoscopic gastrectomy for gastric cancer: a multicenter Real-world clinical study.
Int J Surg
; 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38652275
5.
Discovery of CDK signature and CDK5 as potential biomarkers for predicting prognosis and immunotherapeutic response in gastric cancer peritoneal metastases.
Am J Cancer Res
; 13(9): 4087-4100, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37818084